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We describe herein the synthesis and evaluation of the antileishmanial activity against promastigote 
forms of Leishmania amazonensis and cytotoxicity to murine macrophages of a series of 2-chloro-N-
arylacetamide derivatives. All compounds were active, except one (compound 3). Compound 5 presented 
the most promising results, showing good antileishmanial activity (CI50=5.39±0.67 µM) and moderate 
selectivity (SI=6.36), indicating that further development of this class is worthwhile. Preliminary QSAR 
studies, although not predictive, furnished some insights on the importance of electronic character of 
aryl substituent to biological activity, as well as an indirect influence of hydrophobicity on activity.
Uniterms: Leishmaniasis/treatment. Chloroacetamides. Leishmania amazonensisChloroacetamides/
QSAR.
INTRODUCTION
Leishmaniasis is a neglected tropical disease caused 
by several species of Leishmania protozoa and transmitted 
to humans by the bite of the infected phlebotomine sandfly. 
This important public health problem affects about 12 
million people worldwide, with an annual incidence of 
approximately 1.3 million new cases. Leishmaniasis is 
endemic in 98 countries, spread through Latin America, 
Africa, Asia and southern Europe (WHO, 2015).
There is no effective vaccine in preventing this 
disease and the available chemotherapy consists of 
pentavalent antimony compounds, paromomycin, 
pentamidine, amphotericin B and miltefosine, which are 
not satisfactory drugs for the treatment due to high toxicity 
and costs, as well as their parenteral administration for 
long periods and recent cases of resistance (Jain, Jain, 
2013; McGwire, Satoskar, 2014). Therefore, the search 
for new cheap, potent and safe therapeutic alternatives is 
needed and has been pursued by several groups (Birhan, 
Bekhit, Hymete, 2014; Coimbra et al., 2013; Gómez-
Pérez et al., 2014; Bonano et al., 2014; Gellis et al., 2012; 
Machado et al., 2012).
Several authors reported on the potential of 
2-chloro-N-arylacetamide derivatives as herbicidal 
(Hamm, Speziale, 1956), antifungal (Aschale, 2012; Katke 
et al., 2011) and antibacterial agents (Aschale, 2012; Katke 
et al., 2011; Marco-Contelles, Gomez-Sanchez, 2005). 
Furthermore, these compounds have been widely used 
as intermediates for the synthesis of bioactive substances 
(Amrutkar et al., 2012; Siddiqui et al., 2010; Juddhawala, 
Parekh, Rawal, 2011; Jain et al., 2013; Harkov et al., 
2013), highlighting the relevance of these compounds in 
pharmacological, agricultural and synthetic fields. Their 
biological activity is considered to result from alkylation 
of essential nucleophiles (Jaworski, 1969; Jablonkai, 
2003), especially those containing thiol groups (Jaworski, 
1956), such as glutathione and thiol-containing enzymes 
(Jablonkai, Hatzios, 1991; Jablonkai, Dutka, 1992).
Trypanosomatids present a unique thiol-based 
metabolism which protects these parasites against 
oxidative stress, ensuring their survival in a hostile 
environment (Krauth-Siegel, Comini, 2008). They also 
possess cysteine proteases, thiol-containing enzymes 
S. N. Lavorato, M. C. Duarte, P. H. R. De Andrade, E. A. F. Coelho, R. J. Alves
Braz. J. Pharm. Sci. 2017;53(1):e16067Page 2 / 7
that are essential to life cycle and pathogenicity of the 
parasites (Vermelho et al., 2010), so inhibition of that 
metabolic pathway or these enzymes might impair the 
viability of trypanosomatids. The biological activity of 
2-chloro-N-arylacetamides against trypanosomatids has 
not been described so far. It is likely that these compounds 
alkylate such pivotal targets, causing serious damages 
to parasites. Thus, in this work, we report the synthesis 
of ten 2-chloro-N-arylacetamide derivatives in order to 
evaluate their in vitro antileishmanial activity and calculate 
their half maximal inhibitory concentrations (IC50) 
against Leishmania amazonensis. The cytotoxicity of the 
synthesized compounds to murine macrophages was also 
evaluated and their half maximal inhibitory concentrations 
(CC50) against these cells were calculated. The selectivity 
index (SI) was also calculated based on the ratio between 
CC50 and IC50. We prepared compounds with different 
features regarding hydrophobic, steric and electronic 
characters, which would enable us to study qualitative and 
quantitatively, by QSAR (Quantitative Structure-Activity 
Relationship) analysis, the relationship between the 
structures of tested substances and their biological activity. 
MATERIAL AND METHODS
General: All reactants and solvents were acquired 
from commercial suppliers and used without further 
purification. Melting points were determined on 
Microquímica MQAPF 301 apparatus. IR spectra were 
obtained on a Spectrum One, Perkin-Elmer ATR system. 
1H and 13C NMR spectra were performed on a Bruker 
Avance DPX-200 spectrometer and the proton and carbon 
chemical shifts (δ) are given with respect to TMS. 
Chemistry: Compounds 1-10 were synthesized 
as previously reported by Imamura et al. (2005). The 
yields ranged from 54 to 96%. The compounds were fully 
characterized by their melting points and IR, 1H and 13C 
NMR spectra. The melting points of all compounds are 
consistent with previous reports (Harvill, Herbst, Schreiner, 
1952; Youssef et al., 1976; Tropp, 1928; Basu, Sikdar, 1947; 
Harte, Gunnlaugsson, 2006; Singh, Hashim, Singhal, 2011).
Parasites: Leishmania amazonensis (IFLA/
BR/1967/PH-8) strain was used. Parasites were grown 
at 24 °C in Schneider›s medium (Sigma, St. Louis, MO, 
USA), supplemented with 20% heat-inactivated fetal 
bovine s33erum (FBS, Sigma), 20 mM L-glutamine, 
200 U/mL penicillin, and 100 μg/mL streptomycin, pH 
7.4. Stationary-phase promastigotes were prepared as 
previously described (Coelho et al., 2013).
Mice: Peritoneal macrophages were obtained from 
female BALB/c mice (8 weeks old), which were purchased 
from the Institute of Biological Sciences (ICB) from 
UFMG, and maintained under specific pathogen-free 
conditions. The experimental protocol (code 136/2012) 
was approved by the Animal Use Committee from UFMG 
(CETEA/UFMG) 
Antileishmanial activity: The inhibition of 
Leishmania growth was assessed in vitro by cultivating 
stationary-phase promastigotes of L. amazonensis 
(1 x 106 cells) in the presence of each individual 
compound (0 to 100 µM), in 96-well culture plates 
(Nunc, Nunclon, Roskilde, Denmark), for 48 h at 24 oC. 
A previous titration curve was performed to determine 
the best time of inhibition of L. amazonensis growth by 
incubating the parasites with the evaluated products for 
different periods (data not shown). Cell viability was 
assessed by measuring the cleavage of 2 mg/mL of MTT 
[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide] (Sigma). Absorbances were measured by using 
a multi-well scanning spectrophotometer (Molecular 
Devices, Spectra Max Plus, Canada), at a wavelength 
of 570 nm. Amphotericin B (AmpB, 1 µM) was used as 
a positive control. The concentration of the compounds 
needed to inhibit 50% of the Leishmania viability (IC50) 
was determined by applying the sigmoidal regression 
of the concentration-response curves, using different 
concentrations of the compounds. Data shown are 
representative of three independent experiments, 
performed in triplicate, which presented similar results.
Cytotoxicity assay: The inhibition of 50% of the 
macrophage viability (CC50) was calculated by cultivating 
macrophages (5 x 105 cells) in the presence of each 
individual compound (0 to 200 µM) in 96-well plates for 
48 h, at 37 oC. A previous titration curve was performed 
to determine the best time of inhibition of macrophages 
viability by incubating the parasites with the evaluated 
products for different periods (data not shown). Cell 
viability was assessed by the MTT assay, and AmpB (1 
µM) was used as a control. The selectivity index (SI) was 
calculated by determining the ratio between CC50 and 
IC50. Data shown are representative of three independent 
experiments, performed in triplicate, which presented 
similar results.
Statistical analysis: Data were analyzed using the 
GraphPad Prism software (version 5.0 for Windows). The 
difference among the groups was evaluated by the one-way 
ANOVA, followed by Bonferroni´s post-test for multiple 
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comparisons. Differences were considered significant 
when P<0.05.
QSAR: QSAR regression analyses were executed 
with BuildQSAR program (Oliveira, Gaudio, 2001) 
and Multiple Linear Regression (MLR) was employed. 
2D-QSAR study was performed using as biological 
parameter log (1/IC50), derived from IC50 values for active 
compounds. ClogP and the phenyl substituent constants σR 
and MRR were evaluated as physicochemical descriptors. 
Briefly, ClogP is the calculated octanol-water partition 
coefficient, σR is Hammet’s electronic constant and the 
MRR is the contribution of substituent to molar refractivity, 
being dependent on volume and polarizability. ClogP was 
calculated by MarvinSketch 5.9.3 (ChemAxon, 2012) and 
the substituent constants σR and MRR were obtained from 
Hansch and Leo (1979).
RESULTS AND DISCUSSION
Compounds 1-10 were prepared according to 
Imamura et al. (2005), by reacting the appropriate aniline 
with 2-chloroacetic anhydride in THF, at room temperature 
(Figure 1).
We evaluated the in vitro antileishmanial activity of 
compounds 1-10 against stationary-phase promastigote 
forms of L. amazonensis and the results are shown in Table I. 
Except for compound 3, all 2-chloro-N-arylacetamide 
derivatives showed significant antileishmanial activity. The 
most active compounds were 2, 5 and 8, with IC50 values 
below 6 µM. Interestingly, these compounds possess in 
common an electron-withdrawing aryl substituent, which 
may contribute to improve their potential as alkylating 
agents, by increasing the electrophilic character of 
the carbon alpha to chloro atom by resonance effect. 
The cytotoxicity of compounds was determined 
using macrophages derived from female BALB/c mice 
and the values of CC50 are shown in Table I. The selectivity 
index (SI) for each compound (the ratio between the 
CC50 and IC50 values) was calculated and the data are also 
shown in Table I. According to Pires et al. (2013), a SI 
value above 10 is recommended to ensure the safety of a 
compound. The most selective 2-chloro-N-arylacetamide 
derivative was the compound 5, with a SI of 6.36. Since 
these compounds probably act as alkylating agents, this 
result indicates that the compound 5 could alkylate parasite 
nucleophiles with a moderate selectivity when compared 
with mammalian cell nucleophiles.
In order to study quantitatively the relationship 
between physicochemical properties of synthesized 
TABLE I - Antileishmanial activity (IC50), cytotoxicity profile (CC50) and selectivity index (SI) of compounds 1-10
Compounds IC50±SD (µM)a CC50±SD (µM)b SIc
1 11.41±6.05 46.37±4.29 4.06
2 4.74±0.20 18.52±3.89 3.91
3 Inactive NDd NDd
4 14.42±2.13 22.84±8.70 1.58
5 5.39±0.67 34.28±16.66 6.36
6 11.88±0.80 17.99±1.66 1.51
7 11.91±0.57 17.71±4.89 1.49
8 4.78±1.22 18.50±0.13 3.87
9 18.84±10.86 29.95±4.08 1.59
10 21.01±7.33 25.15±0.21 1.20
AmpBe 0.1±0.02 0.78±0.21 8.0
aIC50: 50% inhibitory concentration on L. amazonensis promastigotes; bCC50: 50% cytotoxicity concentration on macrophages; 
cSI: selective index (CC50/IC50); dND= not determined; eAmpB = Amphotericin B, positive control.
FIGURE 1 - Synthesis of 2-chloro-N-arylacetamide derivatives 
1-10.
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compounds and their antileishmanial activity, a 2D-QSAR 
study was performed. The hydrophobic, electronic and 
steric parameters were evaluated using ClogP and the 
phenyl substituent constants σR and MRR, respectively. 
IC50 values of active compounds were converted into log 
(1/IC50) and used as biological parameters in the QSAR 
study (Table II).
The data set consists of nine points. We evaluated 
different linear models with one or two independent 
variables to obey the condition n/p≥4, where n is the 
number of data points and p is the number of descriptors 
used in QSAR model (Verma, Hansch, 2010). The MLR 
module of BuildQSAR program was used (Oliveira, 
Gaudio, 2001). The obtained QSAR models with statistical 
parameters are shown in Table III.
To determine which QSAR model better describes 
our data, we evaluated several statistical parameters, such 
as the fraction of variance (r2), the correlation coefficient 
(r) and the measure of statistical significance (p). Among 
the QSAR models, we found the best correlation between 
independent and dependent variables with model 1. In 
this model, the compound 4 was considered an outlier. 
Among the predicted QSAR equations, model 1 presented 
the highest r2 value, indicating that this model can explain 
the activity variation in a higher percentage. Moreover, the 
low value of p indicates a higher statistical significance 
of the model regarding the others. The data of observed 
activity values and predicted activity values (calculated 
using model 1) is given in Table II.
By the model 1, a good correlation between the 
antileishmanial activity of this class and Hammet’s 
electronic constant was observed. This constant represents 
TABLE III - QSAR models with statistical parameters.
Regression equation n/pa rb r2c pe Outlier
1 log(1/IC50) = 0.6949(±0.2817)σR + 4.8655(±0.1122) 8 0.927 0.859 0.0009 4
2 log(1/IC50) = 0.0059(±0.3455)ClogP + 4.9873(±0.6485) 9 0.015 0.0002 0.9689 -
3 log(1/IC50) = 0.0263(±0.0431)MRR + 4.7701(±0.4184) 9 0.479 0.230 0.1920 -
4 log(1/IC50) = 0.6521(±0.4272)σR + 0.1314(±0.2271)ClogP + 
4.5972(±0.4726)
4.5 0.836 0.699 0.0272 -
5 log(1/IC50) = 0.5166(±0.5207)σR + 0.0071(±0.0394)MRR + 
4.8037(±0.3338)
4.5 0.782 0.611 0.0587 -
6 log(1/IC50) = 0.0280(±0.0490)MRR + 0.0516(±0.3446)ClogP + 
4.6642(±0.8457)
4.5 0.496 0.246 0.4281 -
an/p: number of data points/number of descriptors; br: correlation coefficient; cr2: fraction of variance; dp: statistical significance.
TABLE II - Physicochemical parameters and observed and calculated biological activity
Compounds R
log (1/IC50)a ClogPc σRd MRReObs. Calc.b ∆
1 H 4.94 4.865 0.075 1.75 0 1.03
2 COOCH2CH3 5.36 5.178 0.182 2.11 0.45 17.49
3 COOH - - - -1.66f 0.45 6.93
4g SO2NH2 4.84 5.262 -0.422 0.35f 0.57 12.28
5 COCH3 5.27 5.213 0.057 1.31 0.50 11.18
6 Cl 4.93 5.025 -0.095 2.35 0.23 6.03
7 Br 4.92 5.025 -0.105 2.52 0.23 8.88
8 NO2 5.32 5.408 -0.088 1.69 0.78 7.36
9 CH3 4.72 4.747 -0.027 2.26 -0.17 5.65
10 OCH3 4.68 4.678 0.002 1.59 -0.27 7.87
aIC50: 50% inhibitory concentration on L. amazonensis promastigotes; bData calculated using model 1 (Table III); cClogP: calculated 
partition coefficient, calculated by MarvinSketch 5.9.3 (ChemAxon, 2012); dσR: Hammet’s electronic constant, obtained from 
Hansch, Leo, 1979; eMRR: molar refractivity, obtained from Hansch and Leo, 1979; f at pH 7.4; gOutlier.
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the electronic effect of a particular substituent. Positive σR 
values mean that the group has an electron withdrawing 
effect and negative values mean that the group has an 
electron donating effect. The parameter r2 indicates that 
this model can explain 85.9% of activity variation. The 
p-value indicates a statistical significance of 99.91%. 
Since we worked with a small data set and the 
external validation of QSAR models could not be 
done, the obtained model does not have a predictive 
value. However, the correlation found between the 
antileishmanial activity and Hammet’s electronic constant 
(σR) can help us to get some insights about the mechanism 
of action of these compounds. The positive coefficient 
of σR means a direct correlation between the dependent 
and independent variables, corroborating previous 
observations that structurally-related compounds bearing 
electron-withdrawing groups present greater activity than 
those with electron donating groups (Céspedes-Camacho 
et al., 2012; Neau et al., 1982). Although compound 4 
(R = SO2NH2) presents a substituent with high positive 
value of σR, it does not follow this tendency, behaving 
like an outlier. This could be explained by its lower 
hydrophobicity, indicated by its low value of ClogP 
(0.35), which may be hindering its passage across the 
lipophylic membranes of parasite. In the same way, one 
could suggest a reason why the compound 3 was inactive. 
In physiological pH, the carboxylic group of compound 3 
is predominantly ionized. Then, if we consider the ionized 
forms in calculating partition coefficient, we obtain a 
ClogP (or calculated distribution coefficient – ClogD) 
of -1.66. This suggests that hydrophobicity could also 
affect the activity when compounds present low values of 
ClogP, although the high σR value. This observation is in 
accordance with Jablonkai (2003), which demonstrates 
that the herbicidal activity of chloracetamides is not simply 
dependent on chemical reactivity, but related to molecular 
properties, including lipophilicity.
CONCLUSION
In conclusion, we have described herein the synthesis 
and evaluation of the antileishmanial activity against 
promastigote forms of L. amazonensis and cytotoxicity 
to murine macrophages of ten 2-chloro-N-arylacetamide 
derivatives. All compounds, but one, present good 
antileishmanial activity, demonstrating for the first time 
the biological potential of this class against Leishmaniasis. 
Moreover, compound 5 (R=COCH3) showed the most 
promising results, with good antileishmanial activity and 
moderate selectivity. By QSAR studies, the influence 
of electronic character of aryl substituent to biological 
activity was demonstrated. The indirect influence of 
hydrophobicity on this activity was also observed. In 
view of the promising antileishmanial activity of some 
compounds of this class, the synthesis of analogues 
possessing high SI is worthwhile. Work in this direction 
is underway and the results will be reported in due time.
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